Drug: doxorubicin hydrochloride Quarter: 2016Q3
Total Records: 406 Number of Pages: 21
| DRUGNAME | PT | EventCount |
|---|---|---|
| DOXORUBICIN HYDROCHLORIDE. | Mass | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Maternal drugs affecting foetus | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Memory impairment | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Metastases to bone | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Metastases to liver | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Mobility decreased | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Mood altered | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Mouth ulceration | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Musculoskeletal disorder | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Myocarditis | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Nasal flaring | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Nasopharyngitis | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Neck pain | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Nephropathy toxic | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Nervous system disorder | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Neutropenic colitis | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Neutrophil count abnormal | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Neutrophil count decreased | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Nonspecific reaction | 1 |
| DOXORUBICIN HYDROCHLORIDE. | Obesity | 1 |
Total Records: 406 Number of Pages: 21